Ab&B Bio-Tech soared as much as 169% in its trading debut in Hong Kong, after retail investors flocked to the Chinese vaccine maker’s initial public offering.
The stock climbed to as high as HK$34.64 ($4.41) per share on Monday morning, more than double its HK$12.90 IPO price, which was set at the low end of the marketed range.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.